Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

DexCom, Inc.

http://www.dexcom.com

Latest From DexCom, Inc.

Finance Watch: Three New IPOs, But Three Hopefuls Hold Back

IPO Edition: Caribou, AbSci and HCW launched initial public offerings, but three firms that were expected to go public during the week of 19-23 July did not, raising the question of whether investors are beginning to pull back from biopharma offerings.

Financing Business Strategies

Digital Health Roundup, June 2021: Winners In Record-Breaking H1 Digital Health Funding; ADA 2021; Telehealth Update

In this roundup feature focusing on the developments in digital health, we highlight the key news and announcements from June.

Digital Health Telehealth

Finance Watch: The Bigger The Better? Erasca, Imago Rise After IPOs

Public Company Edition: Three $100m-plus US initial public offerings launched on 15 July after two smaller biopharma IPOs earlier in the month. Also, Gelesis announced a SPAC merger, Brii and Amniotics launched ex-US IPOs, and Intellia, Cerevel and Kymera priced large follow-on offerings. 

Financing Growth

Dexcom, Abbott File Dueling Lawsuits On Diabetes Management Technology

The two suits address a total of 17 patents on elements of continuous glucose monitors, or CGMs.

Legal Issues Intellectual Property
See All

Company Information

  • Industry
  • Medical Devices
    • Monitoring Equipment & Devices
  • In Vitro Diagnostics
    • Biosensors
    • Glucose Testing
  • Other Names / Subsidiaries
    • SweetSpot Diabetes Care
    • TypeZero Technologies, LLC
UsernamePublicRestriction

Register